| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/09/2023 | DICE Therapeutics, Inc. | DICE | Disposition | Stock Option (right to buy) | 21.2k | $14.98 | $318.3k | | 08/09/2023 |
| 08/09/2023 | DICE Therapeutics, Inc. | DICE | Disposition | Stock Option (right to buy) | 13.8k | $17.00 | $234.6k | | 08/09/2023 |
| 08/09/2023 | DICE Therapeutics, Inc. | DICE | Disposition | Stock Option (right to buy) | 8.3k | $17.00 | $140.4k | | 08/09/2023 |
| 08/09/2023 | DICE Therapeutics, Inc. | DICE | Disposition | Stock Option (right to buy) | 12.1k | $17.00 | $205.6k | | 08/09/2023 |
| 08/09/2023 | DICE Therapeutics, Inc. | DICE | Disposition | Common Stock | 25.7k | $0.00 | $0 | By Trust | 08/09/2023 |
| 08/09/2023 | DICE Therapeutics, Inc. | DICE | Disposition | Common Stock | 15.2k | $0.00 | $0 | | 08/09/2023 |
| 08/02/2023 | DICE Therapeutics, Inc. | DICE | Gift | Common Stock | 220 | $0.00 | $0 | By Trust | 08/02/2023 |
| 08/02/2023 | DICE Therapeutics, Inc. | DICE | Gift | Common Stock | 2.2k | $0.00 | $0 | By Trust | 08/02/2023 |
| 07/11/2023 | DICE Therapeutics, Inc. | DICE | Gift | Common Stock | 300 | $0.00 | $0 | By Trust | 07/11/2023 |
| 05/01/2023 | DICE Therapeutics, Inc. | DICE | Gift | Common Stock | 6.9k | $0.00 | $0 | | 05/01/2023 |
| 05/01/2023 | DICE Therapeutics, Inc. | DICE | Gift | Common Stock | 6.9k | $0.00 | $0 | By Trust | 05/01/2023 |
| 03/17/2023 | DICE Therapeutics, Inc. | DICE | Sale | Common Stock | 10k | $29.05 | $290.5k | By Trust | 10/24/2022 |
| 10/24/2022 | DICE Therapeutics, Inc. | DICE | Gift | Common Stock | 30.7k | $0.00 | $0 | By Trust | 10/24/2022 |
| 10/24/2022 | DICE Therapeutics, Inc. | DICE | Gift | Common Stock | 30.7k | $0.00 | $0 | | 10/24/2022 |
| 06/23/2022 | Aligos Therapeutics, Inc. | ALGS | Grant | Stock Option (Right to Buy) | 15k | $1.34 | $20.1k | | 06/23/2022 |
| 06/10/2022 | Adverum Biotechnologies, Inc. | ADVM | Grant | Stock Option (Right to Buy) | 40k | $0.99 | $39.6k | | 06/10/2022 |
| 06/07/2022 | DICE Therapeutics, Inc. | DICE | Grant | Stock Option (right to buy Common Stock) | 21.2k | $14.98 | $318.3k | | 06/07/2022 |
| 11/15/2021 | Adverum Biotechnologies, Inc. | ADVM | Sale | Common Stock | 50k | $2.18 | $109k | By Trust | 11/15/2021 |
| 09/15/2021 | DICE Therapeutics, Inc. | DICE | Purchase | Common Stock | 6k | $17.00 | $102k | | 09/14/2021 |
| 09/14/2021 | DICE Therapeutics, Inc. | DICE | Grant | Stock Option (right to buy) | 12.1k | $17.00 | $205.6k | | 09/14/2021 |
| 09/14/2021 | DICE Therapeutics, Inc. | DICE | Grant | Stock Option (right to buy) | 8.3k | $17.00 | $140.4k | | 09/14/2021 |
| 09/14/2021 | DICE Therapeutics, Inc. | DICE | Grant | Stock Option (right to buy) | 8.2k | $17.00 | $139.4k | | 09/14/2021 |
| 09/14/2021 | DICE Therapeutics, Inc. | DICE | Grant | Stock Option (right to buy) | 5.6k | $17.00 | $95.2k | | 09/14/2021 |
| 05/12/2021 | Adverum Biotechnologies, Inc. | ADVM | Grant | Stock Option (Right to Buy) | 40k | $3.70 | $148k | | 05/12/2021 |
| 04/26/2021 | Aligos Therapeutics, Inc. | ALGS | Grant | Stock Option (Right to Buy) | 30k | $29.10 | $873k | | 04/26/2021 |
| 06/23/2020 | Adverum Biotechnologies, Inc. | ADVM | Grant | Stock Option (Right to Buy) | 30k | $25.64 | $769.2k | | 06/23/2020 |
| 05/04/2020 | Adverum Biotechnologies, Inc. | ADVM | Exercise | Stock Option (Right to Buy) | 23.3k | $6.48 | $151.2k | | 05/04/2020 |
| 05/04/2020 | Adverum Biotechnologies, Inc. | ADVM | Exercise | Common Stock | 23.3k | $6.48 | $151.2k | By Trust | 05/04/2020 |
| 02/14/2020 | Adverum Biotechnologies, Inc. | ADVM | Purchase | Common Stock | 10k | $13.75 | $137.5k | By Trust | 02/14/2020 |
| 08/15/2019 | Adverum Biotechnologies, Inc. | ADVM | Grant | Stock Option (Right to Buy) | 33.8k | $13.41 | $452.6k | | 08/15/2019 |
| 07/31/2019 | Adverum Biotechnologies, Inc. | ADVM | Grant | Stock Option (Right to Buy) | 11.2k | $13.41 | $150.9k | | 07/31/2019 |
| 05/06/2019 | Adverum Biotechnologies, Inc. | ADVM | Purchase | Common Stock | 20k | $6.71 | $134.2k | By Trust | 05/06/2019 |
| 05/01/2019 | Adverum Biotechnologies, Inc. | ADVM | Grant | Stock Option (Right to Buy) | 70k | $6.48 | $453.6k | | 05/01/2019 |
| 06/21/2018 | Histogen Inc. | CNAT | Grant | Stock Option (Right to Buy) | 20k | $4.99 | $99.8k | | 06/21/2018 |
| 06/22/2017 | Histogen Inc. | CNAT | Grant | Stock Option (Right to Buy) | 20k | $4.96 | $99.2k | | 06/22/2017 |
|